257 related articles for article (PubMed ID: 31395805)
1. Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications.
Oner M; Lin E; Chen MC; Hsu FN; Shazzad Hossain Prince GM; Chiu KY; Teng CJ; Yang TY; Wang HY; Yue CH; Yu CH; Lai CH; Hsieh JT; Lin H
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395805
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
[TBL] [Abstract][Full Text] [Related]
3. Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5.
Hsu FN; Chen MC; Chiang MC; Lin E; Lee YT; Huang PH; Lee GS; Lin H
J Biol Chem; 2011 Sep; 286(38):33141-9. PubMed ID: 21799006
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis.
Lin H; Juang JL; Wang PS
J Biol Chem; 2004 Jul; 279(28):29302-7. PubMed ID: 15123618
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells.
Lindqvist J; Imanishi SY; Torvaldson E; Malinen M; Remes M; Örn F; Palvimo JJ; Eriksson JE
Mol Biol Cell; 2015 Jun; 26(11):1971-84. PubMed ID: 25851605
[TBL] [Abstract][Full Text] [Related]
6. The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line.
Kuo HS; Hsu FN; Chiang MC; You SC; Chen MC; Lo MJ; Lin H
Chin J Physiol; 2009 Feb; 52(1):23-30. PubMed ID: 19764350
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells.
Strock CJ; Park JI; Nakakura EK; Bova GS; Isaacs JT; Ball DW; Nelkin BD
Cancer Res; 2006 Aug; 66(15):7509-15. PubMed ID: 16885348
[TBL] [Abstract][Full Text] [Related]
8. Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells.
Lin H; Chen MC; Chiu CY; Song YM; Lin SY
J Biol Chem; 2007 Feb; 282(5):2776-84. PubMed ID: 17145757
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β1 induces cell cycle arrest by activating atypical cyclin-dependent kinase 5 through up-regulation of Smad3-dependent p35 expression in human MCF10A mammary epithelial cells.
Park SJ; Yang SW; Kim BC
Biochem Biophys Res Commun; 2016 Apr; 472(3):502-7. PubMed ID: 26966064
[TBL] [Abstract][Full Text] [Related]
11. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
Schmid G; Strosznajder JB; Wesierska-Gadek J
Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase 5 regulates steroidogenic acute regulatory protein and androgen production in mouse Leydig cells.
Lin H; Chen MC; Ku CT
Endocrinology; 2009 Jan; 150(1):396-403. PubMed ID: 18755796
[TBL] [Abstract][Full Text] [Related]
13. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
14. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
[TBL] [Abstract][Full Text] [Related]
15. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE
Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
[TBL] [Abstract][Full Text] [Related]
16. Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5.
Goodyear S; Sharma MC
Exp Mol Pathol; 2007 Feb; 82(1):25-32. PubMed ID: 17081516
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.
Hååg P; Bektic J; Bartsch G; Klocker H; Eder IE
J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):251-8. PubMed ID: 15982869
[TBL] [Abstract][Full Text] [Related]
18. p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer.
Oner M; Lin E; Chiu KY; Chen MC; Prince GMSH; Lai CH; Hsieh JT; Wang HY; Lin HO
Anticancer Res; 2024 Feb; 44(2):543-553. PubMed ID: 38307563
[TBL] [Abstract][Full Text] [Related]
19. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
20. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer.
Chatterjee B
Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]